ADDEX THERAPEUTICS LTD (ADXN) Stock Analyst Ratings
NASDAQ:ADXN • US00654J2069
7.315 USD
-0.23 (-2.99%)
Last: Feb 17, 2026, 08:00 PM
ChartMill assigns a Buy % Consensus number of 40% to ADXN. The Buy consensus is the weighted average rating of the current analysts ratings.
- ADXN was analyzed by 9 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ADXN.
- In the previous month the buy percentage consensus was at a similar level.
- ADXN was analyzed by 9 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-31 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2022-06-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-05-31 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-11 | HC Wainwright & Co. | Maintains | Buy |
ADDEX THERAPEUTICS LTD / ADXN FAQ
What is the consensus rating for ADXN stock?
The consensus rating for ADDEX THERAPEUTICS LTD (ADXN) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.